Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit

Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit

Background: Neonatal sepsis is a condition with high mortality and morbidity that contributes to high rates of antibiotic therapy at birth. In addition, very low birth weight newborns (VLBWN) are particularly vulnerable. Interleukin 6 (IL-6) seems to be an early and effective marker that could help...

Full description

Bibliographic Details
Main Authors: Sonia Lareu-Vidal, Gonzalo Solís-Sánchez, María Caunedo-Jiménez, Silvia Martín-Ramos, Marta Costa-Romero, Belén Fernández Colomer
Format: Article
Language:English
Published: Permanyer 2021-01-01
Series:Boletín Médico del Hospital Infantil de México
Subjects:
Interleukin 6. Neonatal sepsis. Antibiotics. Very low-birth weight newborns.
Online Access:https://www.bmhim.com/frame_esp.php?id=267

Internet

https://www.bmhim.com/frame_esp.php?id=267

Similar Items